Skip to main content
. 2020 Aug 19;40(34):6557–6571. doi: 10.1523/JNEUROSCI.0740-20.2020

Table 3.

Histaminergic modulation of corticostriatal fEPSP properties across postnatal developmenta

aCSF Histamine p
P3–P6
    fEPSP amplitude (mV) 0.41 ± 0.10 0.34 ± 0.07 0.56
    fEPSP duration (ms) 241.58 ± 39.55 247.41 ± 35.16 0.92
    fEPSP rise time (ms) 30.02 ± 9.17 30.68 ± 8.59 0.94
    fEPSP decay time (ms) 211.55 ± 30.99 216.74 ± 27.77 0.92
    Short-term plasticity (2 vs 1) 1.48 ± 0.18 1.74 ± 0.30 0.48
    Short-term plasticity (3 vs 1) 1.55 ± 0.20 1.89 ± 0.37 0.44
    Short-term plasticity (4 vs 1) 1.47 ± 0.33 1.86 ± 0.48 0.52
    Short-term plasticity (5 vs 1) 1.48 ± 0.38 1.84 ± 0.52 0.58
    Short-term plasticity (6 vs 1) 1.52 ± 0.38 1.98 ± 0.59 0.53
P9–P12
    fEPSP amplitude (mV) 0.62 ± 0.15 0.50 ± 0.08 0.47
    fEPSP duration (ms) 224.74 ± 48.24 225.52 ± 55.01 0.99
    fEPSP rise time (ms) 24.22 ± 9.89 26.57 ± 10.94 0.88
    fEPSP decay time (ms) 200.52 ± 38.41 198.96 ± 44.26 0.98
    Short-term plasticity (2 vs 1) 1.01 ± 0.18 1.03 ± 0.12 0.93
    Short-term plasticity (3 vs 1) 0.97 ± 0.21 0.91 ± 0.15 0.82
    Short-term plasticity (4 vs 1) 0.93 ± 0.23 0.86 ± 0.20 0.83
    Short-term plasticity (5 vs 1) 0.95 ± 0.25 0.87 ± 0.19 0.82
    Short-term plasticity (6 vs 1) 0.96 ± 0.28 0.89 ± 0.21 0.83
P21–P35
    fEPSP amplitude (mV) 1.74 ± 0.75 1.50 ± 0.65 0.81
    fEPSP duration (ms) 196.93 ± 58.46 188.62 ± 51.16 0.92
    fEPSP rise time (ms) 18.56 ± 8.99 19.50 ± 9.22 0.94
    fEPSP decay time (ms) 178.37 ± 49.69 169.12 ± 42.80 0.89
    Short-term plasticity (2 vs 1) 0.92 ± 0.05 1.19 ± 0.21 0.26
    Short-term plasticity (3 vs 1) 0.79 ± 0.07 1.15 ± 0.25 0.20
    Short-term plasticity (4 vs 1) 0.71 ± 0.09 1.07 ± 0.21 0.17
    Short-term plasticity (5 vs 1) 0.70 ± 0.08 0.97 ± 0.17 0.20
    Short-term plasticity (6 vs 1) 0.67 ± 0.08 1.03 ± 0.20 0.14

aData are mean ± SEM; statistical comparisons by Mann–Whitney U test.